Medical Research News

RSS

Could the high rate of mutations bring about SARS-CoV-2's extinction in India?

A new study published on the preprint server bioRxiv in August 2020 shows the importance of uncovering the dynamics of the virus with particular attention to geographic variation.

19 Aug 2020

Fresh and frozen food can harbor SARS-CoV-2 for at least 21 days

A recent study published on the preprint server bioRxiv in August 2020 suggests that foodborne contamination may underlie these outbreaks and that this route of transmission should not be overlooked to contain the pandemic.

19 Aug 2020

Cytokine storms may prevent the development of long-term immunity to SARS-CoV-2

Shiv Pillai, MD, PhD, investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical School (HMS), recently published a paper in Cell showing that that high levels of some cytokines seen in COVID-19 patients, as part of a cytokine storm, may prevent the development of long-term immunity to SARS-CoV-2, the virus that causes COVID-19.

19 Aug 2020

Study reveals important trends in early COVID-19 patients in Massachusetts

Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.

19 Aug 2020

Genomics study shows multiple and diverse SARS-CoV-2 introductions in the US capital region

A recent study led by the researchers from Johns Hopkins University reveals multiple and diverse introductions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States National Capital Region during the initial phase of coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the medRxiv* preprint server.

19 Aug 2020

Osteoarthritis patients can benefit from a qualified, conservative therapy program

A Norwegian study has now shown how many patients with osteoarthritis (OA) can benefit from a qualified, conservative therapy program.

19 Aug 2020

New database could speed the development of gene-targeted therapies for breast cancer

All current breast cancer drugs were first tested in cell lines. Each cell line began as cancer in a patient. As such, each cell line is a surrogate for that patient's disease.

19 Aug 2020

Lifetime risk of death from firearms, drug overdoses is substantial in the United States

A new study appearing in The American Journal of Medicine, published by Elsevier, calculates the lifetime risk of death from firearms and drug overdoses in the United States.

19 Aug 2020

Older adults with pre-existing depression exhibit resilience to stress during COVID-19

A study involving older adults with pre-existing major depressive disorder living in Los Angeles, New York, Pittsburgh, and St Louis found no increase in depression and anxiety during the COVID-19 pandemic.

19 Aug 2020

Researchers use heparin to block co-receptor for SARS-CoV-2 infection

Researchers at the University of Amsterdam have conducted a study showing that heparan sulfate proteoglycans are important co-receptors that severe acute respiratory syndrome 2 (SARS-CoV-2) requires to infect host cells.

19 Aug 2020

Researchers elucidate mechanisms underlying spatial memory impairment in Alzheimer's

Alzheimer's disease is one of the most serious diseases in an aging society, yet the cause is often unclear and there is no appropriate treatment method.

19 Aug 2020

Human microbiome trims mucosal glycans, influencing SARS-CoV-2 infection

An international team of researchers has conducted a study showing that differences in the human microbiome may influence the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.

19 Aug 2020

Researchers identify drug that improves survival in critically ill COVID-19 patients

Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically ill patients admitted to the intensive care unit.

19 Aug 2020

New approach to chronic pain treatment could bring relief

Something like a quarter of the world's population suffers from chronic pain at some point in their lives. As opposed to acute pain - for example, the feeling after hitting your finger with a hammer - chronic pain may not even have a clear cause, and it can linger for years or lifetimes.

19 Aug 2020

CZI announces $4.5 million to advance novel approaches in neurodegeneration field

Today, the Chan Zuckerberg Initiative announced $4.5 million in funding to support 30 pairs of researchers to collaborate and apply novel approaches for gaining greater insight into neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS.

19 Aug 2020

New treatment increases the speed of nerve regeneration for trauma patients

A University of Alberta researcher has found a treatment that increases the speed of nerve regeneration by three to five times, leading to much better outcomes for trauma surgery patients.

19 Aug 2020

Childhood maltreatment associated with higher chance of multimorbidity in adult life

People who suffer one or more forms of maltreatment in childhood have a higher chance of multimorbidity in later life.

19 Aug 2020

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

In 2018 and 2019, the German Institute for Quality and Efficiency in Health Care already investigated whether the drug enzalutamide has an advantage in comparison with the appropriate comparator therapy, i.e. in comparison with watchful waiting while maintaining ongoing conventional androgen deprivation therapy (ADT), for adult men with high-risk non-metastatic castration-resistant prostate cancer.

19 Aug 2020

COVID-19 patients with hypoxia respond positively to a treatment, study shows

Covid-19 patients with hypoxia respond positively to icatibant treatment, Radboud university medical center researchers wrote in JAMA Network Open.

19 Aug 2020

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Australian researchers have discovered that removing copper from the blood can destroy some of the deadliest cancers that are resistant to immunotherapy using models of the disease.

19 Aug 2020

Medical Research News

Could the high rate of mutations bring about SARS-CoV-2's extinction in India?

Fresh and frozen food can harbor SARS-CoV-2 for at least 21 days

Cytokine storms may prevent the development of long-term immunity to SARS-CoV-2

Study reveals important trends in early COVID-19 patients in Massachusetts

Genomics study shows multiple and diverse SARS-CoV-2 introductions in the US capital region

Osteoarthritis patients can benefit from a qualified, conservative therapy program

New database could speed the development of gene-targeted therapies for breast cancer

Lifetime risk of death from firearms, drug overdoses is substantial in the United States

Older adults with pre-existing depression exhibit resilience to stress during COVID-19

Researchers use heparin to block co-receptor for SARS-CoV-2 infection

Researchers elucidate mechanisms underlying spatial memory impairment in Alzheimer's

Human microbiome trims mucosal glycans, influencing SARS-CoV-2 infection

Researchers identify drug that improves survival in critically ill COVID-19 patients

New approach to chronic pain treatment could bring relief

CZI announces $4.5 million to advance novel approaches in neurodegeneration field

New treatment increases the speed of nerve regeneration for trauma patients

Childhood maltreatment associated with higher chance of multimorbidity in adult life

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

COVID-19 patients with hypoxia respond positively to a treatment, study shows

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News